- Home
- MBRX vs PWM Comparison
MBRX vs PWM Comparison
Compare MBRX & PWM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MBRX
- PWM
- Stock Information
- Founded
- MBRX 2015
- PWM 2018
- Country
- MBRX United States
- PWM Hong Kong
- Employees
- MBRX N/A
- PWM N/A
- Industry
- MBRX Biotechnology: Pharmaceutical Preparations
- PWM
- Sector
- MBRX Health Care
- PWM
- Exchange
- MBRX Nasdaq
- PWM Nasdaq
- Market Cap
- MBRX 11.4M
- PWM 9.1M
- IPO Year
- MBRX 2016
- PWM 2023
- Fundamental
- Price
- MBRX $2.37
- PWM $0.73
- Analyst Decision
- MBRX Strong Buy
- PWM
- Analyst Count
- MBRX 3
- PWM 0
- Target Price
- MBRX $35.00
- PWM N/A
- AVG Volume (30 Days)
- MBRX 30.7K
- PWM 3.0M
- Earning Date
- MBRX 08-14-2024
- PWM 09-17-2024
- Dividend Yield
- MBRX N/A
- PWM N/A
- EPS Growth
- MBRX N/A
- PWM N/A
- EPS
- MBRX N/A
- PWM N/A
- Revenue
- MBRX N/A
- PWM $348,528.00
- Revenue This Year
- MBRX N/A
- PWM N/A
- Revenue Next Year
- MBRX N/A
- PWM N/A
- P/E Ratio
- MBRX N/A
- PWM N/A
- Revenue Growth
- MBRX N/A
- PWM N/A
- 52 Week Low
- MBRX $0.37
- PWM $0.67
- 52 Week High
- MBRX $6.24
- PWM $5.88
- Technical
- Relative Strength Index (RSI)
- MBRX 40.82
- PWM 42.54
- Support Level
- MBRX $2.44
- PWM $0.71
- Resistance Level
- MBRX $2.62
- PWM $1.75
- Average True Range (ATR)
- MBRX 0.17
- PWM 0.15
- MACD
- MBRX 0.05
- PWM -0.03
- Stochastic Oscillator
- MBRX 32.08
- PWM 6.01
About MBRX Moleculin Biotech Inc.
Moleculin Biotech Inc is a clinical stage pharmaceutical company focused on the development of a broad portfolio of drug candidates for the treatment of highly resistant tumors and viruses. The company's lead program, Annamycin is a next-generation anthracycline designed to avoid multidrug resistance mechanisms with little to no cardiotoxicity.
About PWM Prestige Wealth Inc.
Prestige Wealth Inc is engaged in providing private wealth management services and asset management to high-net-worth and ultra-high-net-worth individuals and enterprises through its subsidiaries.